UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Mimicry of a Conceptual Hydrological Model (HBV): What's in a Name?

Water resources research, 2021-05, Vol.57 (5), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)

Journal of medicinal chemistry, 2014-04, Vol.57 (7), p.3053-3074

2014

Link zum Volltext

Verfügbarkeit prüfen

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR

Frontiers in immunology, 2018-05, Vol.9, p.1062-1062

2018

Link zum Volltext

Verfügbarkeit prüfen

Two years after in vivo implantation of poly(DL-lactide-ε-caprolactone) nerve guides: Has the material finally resorbed?

Journal of Biomedical Materials Research Part B, 2009-06, Vol.89A (3), p.734-738

2009

Link zum Volltext

Verfügbarkeit prüfen

Improving printability of limestone-calcined clay-based cementitious materials by using viscosity-modifying admixture

Cement and concrete research, 2020-06, Vol.132, p.106040, Article 106040

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of printing parameters on interlayer bond strength of 3D printed limestone-calcined clay-based cementitious materials: An experimental and numerical study

Construction & building materials, 2020-11, Vol.262, p.120094, Article 120094

2020

Link zum Volltext

Verfügbarkeit prüfen

In vitro degradation and biocompatibility of poly(DL-lactide-ϵ-caprolactone) nerve guides

Journal of biomedical materials research, 2004-01, Vol.68A (1), p.43-51

2004

Link zum Volltext

Verfügbarkeit prüfen

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

ACS medicinal chemistry letters, 2013-05, Vol.4 (5), p.491-496

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)

ACS medicinal chemistry letters, 2019-08, Vol.10 (8), p.1173-1179

2019

Link zum Volltext

Verfügbarkeit prüfen

TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product

Molecular therapy, 2020-02, Vol.28 (2), p.561-571

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-104: Targeting solid malignancies with TEGs: αβT cells e ngineered to express a defined γδTCR in xenograft mice model

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-104-LB-104

2018

Link zum Volltext

Verfügbarkeit prüfen

Circadian Rhythms of C-FOS Expression in the Suprachiasmatic Nuclei of the Common Vole (Microtus arvalis)

Chronobiology international, 2008-01, Vol.25 (4), p.481-499

2008

Link zum Volltext

Verfügbarkeit prüfen

Towards the Next Generation CAR T Cells with TEGs: In Vivo Efficacy — Toxicity Profile in Xenografts of Primary Human AML Disease and Healthy Bone Marrow

Blood, 2017-12, Vol.130, p.3336-3336

2017

Link zum Volltext

Verfügbarkeit prüfen

Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (10), p.3412-3417

2012

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

MedChemComm, 2014-11, Vol.5 (11), p.1700-1707

2014

Link zum Volltext

Verfügbarkeit prüfen

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined [GAMMA][DELTA]TCR

Frontiers in immunology, 2018-05

2018

Link zum Volltext

Verfügbarkeit prüfen

Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation

MedChemComm, 2016-03, Vol.7 (3), p.433-438

2016

Link zum Volltext

Verfügbarkeit prüfen

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport

Biofabrication, 2017-06, Vol.9 (3), p.035001-035001

2017

Link zum Volltext

Verfügbarkeit prüfen

Potent and selective inhibitors of fibroblast activation protein (FAP)

Jansen, Koen

2014

Link zum Volltext
ProQuest

Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variationElectronic supplementary information (ESI) available: Experimental details for unreported P1-residues, analytical data of final products and enzymatic assay protocols. See DOI: 10.1039/c5md00454c

2016-03

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffoldElectronic supplementary information (ESI) available: Detailed synthesis protocols and analytical data for the compounds. See DOI: 10.1039/c4md00167b

2014-10

Link zum Volltext

Verfügbarkeit prüfen

Long-term regeneration of the rat sciatic nerve through a biodegradable poly(DL-lactide-ϵ-caprolactone) nerve guide: Tissue reactions with focus on collagen III/IV reformation

Journal of biomedical materials research, 2004-05, Vol.69A (2), p.334-341

2004

Link zum Volltext

Verfügbarkeit prüfen

Vasopressin immunoreactivity, but not vasoactive intestinal polypeptide, correlates with expression of circadian rhythmicity in the suprachiasmatic nucleus of voles

Neuropeptides (Edinburgh), 2007-08, Vol.41 (4), p.207-216

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Mimicry of a Conceptual Hydrological Model (HBV): What's in a Name?

Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)

Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR

Two years after in vivo implantation of poly(DL-lactide-ε-caprolactone) nerve guides: Has the material finally resorbed?

Improving printability of limestone-calcined clay-based cementitious materials by using viscosity-modifying admixture

Effect of printing parameters on interlayer bond strength of 3D printed limestone-calcined clay-based cementitious materials: An experimental and numerical study

In vitro degradation and biocompatibility of poly(DL-lactide-ϵ-caprolactone) nerve guides

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector

Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)

TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product

Abstract LB-104: Targeting solid malignancies with TEGs: αβT cells e ngineered to express a defined γδTCR in xenograft mice model

Circadian Rhythms of C-FOS Expression in the Suprachiasmatic Nuclei of the Common Vole (Microtus arvalis)

Towards the Next Generation CAR T Cells with TEGs: In Vivo Efficacy — Toxicity Profile in Xenografts of Primary Human AML Disease and Healthy Bone Marrow

Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined [GAMMA][DELTA]TCR

Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport

Potent and selective inhibitors of fibroblast activation protein (FAP)

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffoldElectronic supplementary information (ESI) available: Detailed synthesis protocols and analytical data for the compounds. See DOI: 10.1039/c4md00167b

Long-term regeneration of the rat sciatic nerve through a biodegradable poly(DL-lactide-ϵ-caprolactone) nerve guide: Tissue reactions with focus on collagen III/IV reformation

Vasopressin immunoreactivity, but not vasoactive intestinal polypeptide, correlates with expression of circadian rhythmicity in the suprachiasmatic nucleus of voles

Suchergebnisse filtern